We are live on ! Find out more
AIM

Axiom Investment Management Portfolio holdings

AUM $150M
This Fund
S&P 500
This Quarter Est. Return
-10.5%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$34.8M
AUM Growth
-$11.2M
Cap. Flow
-$6.52M
Cap. Flow %
-18.75%
Top 10 Hldgs %
37%
Holding
103
New
16
Increased
15
Reduced
23
Closed
27

Top Buys

Rank Stock Value
1
PSQ icon
ProShares Short QQQ
PSQ
+$1.26M
2
UNP icon
Union Pacific
UNP
+$854K
3
F icon
Ford
F
+$585K
4
QCOM icon
Qualcomm
QCOM
+$469K
5
NEM icon
Newmont
NEM
+$456K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.81M
2
RTX icon
RTX Corp
RTX
+$736K
3
SH icon
ProShares Short S&P500
SH
+$679K
4
EXEL icon
Exelixis
EXEL
+$533K
5
CVX icon
Chevron
CVX
+$501K

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Financials 12.9%
3 Technology 12.64%
4 Industrials 12.45%
5 Communication Services 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$631B
$479K 1.38%
2,696
-54
-2% -$9.62K
REGN icon
27
Regeneron Pharmaceuticals
REGN
$83.2B
$473K 1.36%
800
– –
F icon
28
Ford
F
$55.8B
$472K 1.36%
+42,700
New +$585K
CSX icon
29
CSX Corp
CSX
$92.8B
$468K 1.35%
16,162
+872
+6% +$28.4K
GE icon
30
GE Aerospace
GE
$380B
$457K 1.31%
11,467
-3,709
-24% -$180K
QCOM icon
31
Qualcomm
QCOM
$170B
$440K 1.27%
+3,455
New +$469K
BAC icon
32
Bank of America
BAC
$447B
$430K 1.24%
13,785
-1,087
-7% -$39.1K
Y
33
DELISTED
Alleghany Corp
Y
$428K 1.23%
514
– –
LRCX icon
34
Lam Research
LRCX
$383B
$426K 1.22%
10,000
-4,000
-29% -$190K
NVDA icon
35
NVIDIA
NVDA
$5.27T
$401K 1.15%
26,470
-2,860
-10% -$54K
RPRX icon
36
Royalty Pharma
RPRX
$25.8B
$395K 1.14%
+9,400
New +$385K
FWONK icon
37
Liberty Media Series C
FWONK
$25.8B
$384K 1.1%
6,247
– –
NEM icon
38
Newmont
NEM
$124B
$382K 1.1%
+6,450
New +$456K
SPG icon
39
Simon Property Group
SPG
$71.5B
$379K 1.09%
4,000
– –
HBAN icon
40
Huntington Bancshares
HBAN
$35.6B
$361K 1.04%
30,000
– –
V icon
41
Visa
V
$675B
$354K 1.02%
1,801
-7
-0.4% -$1.45K
PG icon
42
Procter & Gamble
PG
$340B
$336K 0.97%
2,346
+61
+3% +$9.17K
NXPI icon
43
NXP Semiconductors
NXPI
$58.9B
$315K 0.91%
2,132
-6
-0.3% -$1.04K
GSK icon
44
GSK
GSK
$104B
$308K 0.89%
+5,600
New +$309K
BIZD icon
45
VanEck BDC Income ETF
BIZD
$1.68B
$302K 0.87%
+20,000
New +$327K
TMO icon
46
Thermo Fisher Scientific
TMO
$222B
$282K 0.81%
521
-3
-0.6% -$1.65K
GDX icon
47
VanEck Gold Miners ETF
GDX
$27.6B
$267K 0.77%
+9,800
New +$331K
KO icon
48
Coca-Cola
KO
$374B
$262K 0.75%
4,180
-904
-18% -$57.3K
ICE icon
49
Intercontinental Exchange
ICE
$84.5B
$261K 0.75%
2,761
-93
-3% -$9.94K
SLP icon
50
Simulations Plus
SLP
$371M
$247K 0.71%
5,000
– –
1
2
3 4 5

Similar funds

AIA
Accelerate Investment Advisors Aliso Viejo, California $150M AUM 17.82% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LGM
L1 Global Manager Melbourne $149M AUM
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return
CRIG
Charter Research & Investment Group Southport, Connecticut $150M AUM 28.05% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return

Axiom Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Axiom Investment Management held 103 positions worth $34.8M, down 24% from $46M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Axiom Investment Management withdrew a net $6.52M in Q2 2022, closing 27 positions and reducing 23 holdings. Its most notable exit was RTX Corp, an estimated $736K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

Against the trend, Axiom Investment Management opened a new position in ProShares Short QQQ worth $1.36M.

  • Axiom Investment Management's largest Q2 2022 buy was ProShares Short QQQ: 18,886 shares worth $1.36M.
  • Axiom Investment Management added most to Abbott in Q2 2022, an estimated $249K increase.
  • Axiom Investment Management's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $2.81M.
  • Axiom Investment Management fully exited RTX Corp in Q2 2022, selling an estimated $736K.
  • Axiom Investment Management's ten largest holdings make up 37% of its $34.8M portfolio in Q2 2022.
  • Axiom Investment Management opened 16 new positions and closed 27 in Q2 2022.
  • Axiom Investment Management's portfolio value fell 24% quarter-over-quarter to $34.8M.

Based on Axiom Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.